News | March 19, 2022
Govt to deploy Truenat platform for TB screening across India
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
Subscribe To Our Newsletter & Stay Updated
